Spinal Simplicity Gains Investor Support from Nueterra

By Julie A. Vetalice

Spinal Simplicity closed a financing round with an investment from Nueterra Capital. Funds will support U.S. launch of the Minuteman fusion device to treat low back pain.

Minuteman received CE Mark approval in 2011; in 2015, Spinal Simplicity received FDA 510(k) clearance for the HA Minuteman G3 MIS Fusion Plate and Minuteman Percutaneous Interlaminar Fusion system. The device, available in five sizes, is pre-packaged sterile and will be offered with hydroxyapatite coating to facilitate fusion.

Further, the investment provides access to the global NueHealth system of healthcare providers.

Sources: Spinal Simplicity, LLC; ORTHOWORLD Inc.

 

Product Labels: Spinal Fusion

Tags: Funding